Welcome to OVG
The Oxford Vaccine Group has been at the forefront of vaccine development for 30 years, helping to fight diseases of major global importance through research and education around the world.
What's Happening?
30 Years of OVG
1994 - 2024
Join our celebrations and learn about 30 years of ground-breaking research at OVG
Study Spotlight
| BiVISTA👤 18 to 55 years old 📅 24 to 31 visits over 7 months 💉1 vaccination and 1 challenge 🧬 Could you be a part of the battle against Typhoid and Paratyphoid fever? 🪙 Up to £4585 reimbursement |
Be a Vaccine Hero
Take part in a study
Could you be a Vaccine Hero by taking part in one of our clinical trials? Find out about the trials and studies currently looking for volunteers, as well as what it is like taking part from previous participants
Study - MUCOSAL
Help us investigate the response of cells in the nose, lung and blood after respiratory infections.
Study - ECLIPSE
A study to understand how the body reacts to a combination of the flu virus and pneumococcal bacteria.
Study - BIO-005
Help us find a safe and effective malaria vaccine!
Research at OVG
Education, Learning and Public Involvement
Latest Publications
⠀⠀⠀⠀⠀
-
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development
Journal article
Siegal EZ. et al, (2025), npj Vaccines, 10
-
Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies.
Journal article
Kantor J. et al, (2025), Hum Vaccin Immunother, 21
-
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: a multi-country analysis
Journal article
Li X. et al, (2025), BMC Medicine, 23
-
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants
Journal article
Guo L. et al, (2025), Nature Communications, 16
Working Together
National Immunisation Schedule Evaluation Consortium II
OVG is proud to lead NISEC II, a collaboration between a network of Academic Clinical Research groups and the UK Health Security Agency.
Immune Memory and Mechanisms of Protection from Vaccines
Oxford is proud to host the IMMPROVE consortium of universities, government, industry and others.
